PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmyelomonocytic leukemia chronic
MeSH D015477 - myelomonocytic leukemia chronic
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D002908:Chronic disease
0 Companies
0 Drugs
Success rate
D007951:Myeloid leukemia
32 Companies
8 Drugs
$
Success rate
D054437:Myelodysplastic-myeloproliferative diseases
22 Companies
1 Drug
$
Success rate
D015477: 
Myelomonocytic leukemia chronic
18 Companies
1 Drug
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
MylanAzacitidine Azacitidine  2016-04-28   
Azacitidine Azacitidine Mylan  2020-03-27   
CiplaAzacitidine Azacitidine  2018-05-04   
Lupin ResearchAzacitidine Azacitidine  2019-02-27   
Dr Reddys LaboratoriesAzacitidine Azacitidine  2013-09-16   
Amneal PharmaceuticalsAzacitidine Azacitidine  2022-02-03   
NATCO PharmaAzacitidine Azacitidine  2017-06-23   
Bristol Myers SquibbAzacitidine Onureg 2029-05-14 2020-09-01 $168 M Y2023 
Azacitidine Vidaza  2004-05-19 $200 M Q4/20-Q3/21 
Accord HealthcareAzacitidine Azacitidine  2018-07-02   
Azacitidine Azacitidine Accord  2020-02-13   
CelgeneAzacitidine Azacitidine Celgene  2019-08-02   
Eurohealth InternationalAzacitidine Azacitidine  2020-06-08   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
63%
84/133
Phase 2
27%
31/113
Phase 3
7%
3/41
Approved: 2Overall Success rate: 1%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Bristol Myers Squibb
Azacitidine
Celgene
Azacitidine,
Phenylalanine,
Bevifimod,
Decellularized dermal allograft,
Histone-arginine methyltransferase carm1,
Surlorian,
Cc5013
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use